A 52-year-old woman with newly diagnosed type 2 diabetes presents with nausea, fatigue, and rapid shallow breathing. ABG shows pH 7.18, PaCO₂ 22 mmHg, HCO₃⁻ 8 mEq/L, and anion gap 20 mEq/L. Blood glucose is 580 mg/dL. Which single investigation is most specific for confirming the primary diagnosis?

Explanation

## Clinical Presentation This patient presents with **diabetic ketoacidosis (DKA)**: - High anion gap metabolic acidosis (AG = 20) - Severe hyperglycemia (580 mg/dL) - Respiratory compensation (low PaCO₂ = 22) - Classic symptoms: nausea, fatigue, Kussmaul respirations ## Why Serum Beta-Hydroxybutyrate? **Key Point:** Serum beta-hydroxybutyrate is the **gold standard and most specific test** for confirming DKA. It is the predominant ketone body produced during DKA (accounts for ~70% of total ketones) and directly reflects the severity of ketosis. ### Beta-Hydroxybutyrate vs. Urine Ketones | Feature | Serum Beta-Hydroxybutyrate | Urine Ketones | |---------|---------------------------|---------------| | **Specificity** | Highest; directly measures ketone body | Moderate; detects acetoacetate & acetone, not beta-hydroxybutyrate | | **Sensitivity** | Detects early/mild ketosis | May be negative in early DKA | | **Quantification** | Precise; correlates with severity | Semi-quantitative only | | **Clinical Use** | Diagnosis & monitoring response to therapy | Screening only | | **Timing** | Reflects current ketosis | Reflects past ketone excretion | **High-Yield:** In DKA, urine ketones may be **falsely negative or weakly positive** because: 1. Urine dipstick detects acetoacetate and acetone, NOT beta-hydroxybutyrate 2. During DKA, beta-hydroxybutyrate (70%) >> acetoacetate (30%) 3. As DKA resolves with insulin, acetoacetate increases (paradoxical increase in urine ketones) **Clinical Pearl:** A patient with clinical DKA but negative urine ketones should have serum beta-hydroxybutyrate measured to avoid missing the diagnosis. ## Diagnostic Specificity ```mermaid flowchart TD A[High AG Metabolic Acidosis + Hyperglycemia]:::outcome --> B{Serum Beta-Hydroxybutyrate?}:::decision B -->|Elevated| C[DKA Confirmed]:::action B -->|Normal| D[Exclude DKA]:::action D --> E[Consider HHS or other AG acidosis]:::outcome C --> F[Insulin + IV fluids + K+ monitoring]:::action ``` [cite:Harrison 21e Ch 417]